Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / email-cross-to-staines-sec-disclosure-20231125.eml
email-cross-to-staines-sec-disclosure-20231125.eml
Parties
Penterra Pharmaceuticals Corp
Penterra BioInnovation Ireland Ltd
Ridgeview Capital Management LP
Harkness LLP
Dates
November 25, 2023
December 31, 2023
October 12, 2023
November 8, 2023
December 22, 2023
Amounts
$380.4
$235.01
$188.04
$42.65
$15.98
$79.88
$95.86
$62.4
$278
$361
Obligations
4 million proposed adjustment represents a significant contingent liability that must be evaluated under ASC 450-20 (formerly FAS 5) for both disclosure and accrual purposes
That said, a contingency of this magnitude must be disclosed, and the 10-K language must be carefully crafted to acknowledge the examination without prejudicing PPC's defense position